Legis Daily

To accelerate patient access to innovative medicines and clinical trials for life-threatening diseases by establishing a reciprocal approval mechanism with trusted international regulatory authorities.

USA119th CongressHR-7953| House 
| Updated: 3/17/2026
Pete Sessions

Pete Sessions

Republican Representative

Texas

Cosponsors (1)
Scott H. Peters (Democratic)

Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Timeline
Mar 17, 2026
Introduced in House
Mar 17, 2026
Referred to the House Committee on Energy and Commerce.
  • March 17, 2026
    Introduced in House


  • March 17, 2026
    Referred to the House Committee on Energy and Commerce.

To accelerate patient access to innovative medicines and clinical trials for life-threatening diseases by establishing a reciprocal approval mechanism with trusted international regulatory authorities.

USA119th CongressHR-7953| House 
| Updated: 3/17/2026
Timeline
Mar 17, 2026
Introduced in House
Mar 17, 2026
Referred to the House Committee on Energy and Commerce.
  • March 17, 2026
    Introduced in House


  • March 17, 2026
    Referred to the House Committee on Energy and Commerce.
Pete Sessions

Pete Sessions

Republican Representative

Texas

Cosponsors (1)
Scott H. Peters (Democratic)

Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted